ChronLAW.com News for attorneys, lawyers, and insurance, banking, credit, finance, government, education and law related professionals, covering politics, business, medicine, crime, law enforcement and other legal topics.
An unusual Federal Circuit decision has given generic drugmakers a new way to successfully...
Generic Drugmakers Score Big in Rare Federal Circuit Reversal – Bloomberg Law
An unusual Federal Circuit decision has given generic drugmakers a new way to successfully challenge pharmaceutical patents with specific types of claims. Novartis Pharmaceuticals Corp.‘s patent on the dosage regimen for the blockbuster multiple…